EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 March 5, 2026 To Our Shareholders, The past eight months have seen CQENS make significant progress toward our goal of expanding our valuable, worldwide Intellectual Property (“IP”) portfolio, securing US FDA authorization to launch a modified risk tobacco product in the US, and making significant progress with respect to listing our shares for trading in the public market. In terms of our Intellectual Property (“IP”), during the recent period, we have added to our patent portfolio in the US and in countries in Asia and throughout the European Union. This is in keeping with our strategy of focusing our IP efforts on building a broad and deep “moat” to safeguard the design and the details of our proprietary, patented, and patent pending Heated Tobacco Product (“HTP”), On the US regulatory front, we met with the FDA late in 2025. It is the responsibility of the FDA to thoroughly review our Pre-market Tobacco Authorization (“PMTA”), and to make the determination as to whether we secure the necessary authorization to launch our HTP in the US. In addition, it is important to note that the PMTA is the “gold standard” for international aut…
Open exhibit ↗Current Report · Items 5.02, 7.01, 9.01 · 8-K
CQENS Technologies Inc.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On March 5, 2026, the Company. distributed a letter to its shareholders of record as of March 5, 2026 providing a review of the company’s recent developments and overview and update on the Company’s plan of operations. A copy of this letter is furnished as Exhibit 99.1 to this report.…
Disclosure sections
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01
Regulation FD Disclosure.
On
March 5, 2026, the Company. distributed a letter to its shareholders of record as of March 5, 2026 providing a review of the company’s
recent developments and overview and update on the Company’s plan of operations. A copy of this letter is furnished as Exhibit
99.1 to this report.
Pursuant
to General Instruction B.2 of Form 8-K, the information in this Item 7.01 of Form 8-K, including Exhibit 99.1, is being furnished and
shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise be subject
to the liabilities of that section, nor is it incorporated by reference into any filing of the company under the Securities Act of 1933
or the Securities Exchange Act of 1934, whether made before or after the date hereof, regardless of any general incorporation language
in such filing.